QR code

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates

Carbapenems are commonly used to treat infections caused by multidrug-resistant (MDR) bacteria. Unfortunately, carbapenem resistance is increasingly reported in many gram-negative bacteria, especially Acinetobacter baumannii. Diazabicyclooctane (DBO) β-lactamase inhibitors, such as avibactam (AVI),...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Jose Cedano, Michelle Baez, Fernando Pasteran, Sabrina Daiana Montaña, Grace Ra, Venjaminne Fua, Alejandra Corso, Marcelo E. Tolmasky, Robert A. Bonomo, María Soledad Ramírez
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2022-07-01
Reeks:Frontiers in Cellular and Infection Microbiology
Onderwerpen:
Acinetobacter
carbapenem-resistance
zidebactam
sulbactam
DBOs
synergy
Online toegang:https://www.frontiersin.org/articles/10.3389/fcimb.2022.918868/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items